Nuclear Medicine and Biology
Volume 34, Issue 8 , Pages 967-971 , November 2007

(E)-[125I]-5-AOIBV: a SPECT radioligand for the vesicular acetylcholine transporter

  • Patrick Emond

      Affiliations

    • INSERM U619, 37000 Tours, France
    • Université François-Rabelais de Tours, CHRU, Hôpital Bretonneau, Service de Médecine nucléaire, 37000 Tours, France
    • ,
  • Sylvie Mavel

      Affiliations

    • INSERM U619, 37000 Tours, France
    • Université François-Rabelais de Tours, CHRU, Hôpital Bretonneau, Service de Médecine nucléaire, 37000 Tours, France
    • Corresponding Author InformationCorresponding author. Faculté de Pharmacie, Laboratoire de Biophysique Médicale et Pharmaceutique, 37200 Tours, France. Tel.: +33 2 47 36 72 40; fax: +33 2 47 36 72 24.
    • ,
  • Yolanda Zea-Ponce

      Affiliations

    • INSERM U619, 37000 Tours, France
    • Université François-Rabelais de Tours, CHRU, Hôpital Bretonneau, Service de Médecine nucléaire, 37000 Tours, France
    • ,
  • Michael Kassiou

      Affiliations

    • Discipline of Medical Radiation Sciences, Brain and Mind Research Institute, University of Sydney, NSW 2050, Australia
    • School of Chemistry, University of Sydney, NSW 2006, Australia
    • ,
  • Lucette Garreau

      Affiliations

    • INSERM U619, 37000 Tours, France
    • Université François-Rabelais de Tours, CHRU, Hôpital Bretonneau, Service de Médecine nucléaire, 37000 Tours, France
    • ,
  • Sylvie Bodard

      Affiliations

    • INSERM U619, 37000 Tours, France
    • Université François-Rabelais de Tours, CHRU, Hôpital Bretonneau, Service de Médecine nucléaire, 37000 Tours, France
    • ,
  • Marie-Laure Drossard

      Affiliations

    • INSERM U619, 37000 Tours, France
    • Université François-Rabelais de Tours, CHRU, Hôpital Bretonneau, Service de Médecine nucléaire, 37000 Tours, France
    • ,
  • Sylvie Chalon

      Affiliations

    • INSERM U619, 37000 Tours, France
    • Université François-Rabelais de Tours, CHRU, Hôpital Bretonneau, Service de Médecine nucléaire, 37000 Tours, France
    • ,
  • Denis Guilloteau

      Affiliations

    • INSERM U619, 37000 Tours, France
    • Université François-Rabelais de Tours, CHRU, Hôpital Bretonneau, Service de Médecine nucléaire, 37000 Tours, France

Received 12 April 2007 ,Revised 13 July 2007 ,Accepted 16 July 2007.

References 

  1. Parsons SM, Bahr BA, Rogers GA, Clarkson ED, Noremberg K, Hicks BW. Acetylcholine transporter-vesamicol receptor pharmacology and structure. Prog Brain Res. 1993;98:175–181
  2. Bahr BA, Clarkson ED, Rogers GA, Noremberg K, Parsons SM. A kinetic and allosteric model for the acetylcholine transporter-vesamicol receptor in synaptic vesicles. Biochemistry. 1992;31:5752–5762
  3. Altar CA, Marien MR. [3H]Vesamicol binding in brain: autoradiographic distribution, pharmacology, and effects of cholinergic lesions. Synapse. 1988;2:486–493
  4. Bahr BA, Parsons SM. Demonstration of a receptor in Torpedo synaptic vesicles for the acetylcholine storage blocker l-trans-2-(4-phenyl[3,4-3H]-piperidino) cyclohexanol. Proc Natl Acad Sci U S A. 1986;83:2267–2270
  5. Wannan G, Prior C, Marshall IG. α-Adrenoceptor blocking properties of vesamicol. Eur J Pharmacol. 1991;201:29–34
  6. Efange SMN, Mach RH, Smith CR, Khare AB, Foulon C, Akella SK, et al. Vesamicol analogues as sigma ligands. Molecular determinants of selectivity at the vesamicol receptor. Biochem Pharmacol. 1995;49:791–797
  7. Efange SMN, Dutta AK, Michelson RH, Kung HF, Thomas JR, Billings J, et al. Radioiodinated 2-hydroxy-3-(4-iodophenyl)-1-(4-phenylpiperidinyl)propane: potential radiotracer for mapping central cholinergic innervation in vitro. Int J Rad Appl Instrum B. 1992;19:337–348
  8. Efange SMN, Michelson RH, Khare AB, Thomas JR. Synthesis and tissue distribution of (m-[125I]iodobenzyl)trozamicol ([125I]MIBT): potential radioligand for mapping central cholinergic innervation. J Med Chem. 1993;36:1754–1760
  9. Shiba K, Mori H, Matsuda H, Tsuji S, Tonami N, Hisada K. In vivo characterization of radioiodinated 2-(4-phenylpiperidino)cyclohexanol (vesamicol) analogs: potential radioligand for mapping presynaptic cholinergic neurons. Nucl Med Biol. 1995;22:823–828
  10. Van Dort ME, Jung YW, Gildersleeve DL, Hagen CA, Kuhl DE, Wieland DM. Synthesis of the 123I- and 125I-labeled cholinergic nerve marker (−)-5-iodobenzovesamicol. Nucl Med Biol. 1993;20:929–937
  11. Jung YW, Van Dort ME, Gildersleeve DL, Wieland DM. A radiotracer for mapping cholinergic neurons of the brain. J Med Chem. 1990;33:2065–2068
  12. Sorger D, Schliebs R, Kampfer I, Rossner S, Heinicke J, Dannenberg C, et al. In vivo [125I]-iodobenzovesamicol binding reflects cortical cholinergic deficiency induced by specific immunolesion of rat basal forebrain cholinergic system. Nucl Med Biol. 2000;27:23–31
  13. Kuhl DE, Minoshima S, Fessler JA, Frey KA, Foster NL, Ficaro EP, et al. In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease. Ann Neurol. 1996;40:399–410
  14. Kuhl DE, Koeppe RA, Fessler JA, Minoshima S, Ackermann RJ, Carey JE, et al. In vivo mapping of cholinergic neurons in the human brain using SPECT and IBVM. J Nucl Med. 1994;35:405–410
  15. Jung YW, Frey KA, Mulholland GK, del Rosario R, Sherman PS, Raffel DM, et al. Vesamicol receptor mapping of brain cholinergic neurons with radioiodine-labeled positional isomers of benzovesamicol. J Med Chem. 1996;39:3331–3342
  16. Assaad T, Mavel S, Parsons SM, Kruse S, Galineau L, Allouchi H, et al. Synthesis and in vitro evaluation of N-substituted aza-trozamicol analogs as vesicular acetylcholine transporter ligands. Bioorg Med Chem Lett. 2006;16:2654–2657
  17. Zea-Ponce Y, Mavel S, Assaad T, Kruse SE, Parsons SM, Emond P, et al. Synthesis and in vitro evaluation of new benzovesamicol analogues as potential imaging probes for the vesicular acetylcholine transporter. Bioorg Med Chem. 2005;13:745–753
  18. Rogers GA, Parsons SM, Anderson DC, Nilsson LM, Bahr BA, Kornreich WD, et al. Synthesis, in vitro acetylcholine-storage-blocking activities, and biological properties of derivatives and analogues of trans-2-(4-phenylpiperidino)cyclohexanol (vesamicol). J Med Chem. 1989;32:1217–1230
  19. Assaad T, Mavel S, Emond P, Chalon S, Drossard ML, Vergote J, et al. Synthesis and ex vivo evaluation of aza-trozamicol analogs as SPECT radiotracers for exploration of the vesicular acetylcholine transporter. J Label Compd Radiopharm. 2007;50:139–145
  20. Mulholland GK, Jung YW, Wieland DM, Kilbourn MR, Kuhl DE. Synthesis of [18F]-fluoroethoxybenzovesamicol, a radiotracer for cholinergic neurons. J Label Compd Radiopharm. 1993;33:583–591
  21. Bando K, Naganuma T, Taguchi K, Ginoza Y, Tanaka Y, Koike K, et al. Piperazine analog of vesamicol: in vitro and in vivo characterization for vesicular acetylcholine transporter. Synapse. 2000;38:27–37
  22. Quirion R. Characterization and autoradiographic distribution of hemicholinium-3 high-affinity choline uptake sites in mammalian brain. Synapse. 1987;1:293–303
  23. Stavinoha WB, Weintraub ST, Modak AT. Regional concentrations of choline and acetylcholine in the rat brain. J Neurochem. 1974;23:885–886

☆ This work was supported by INSERM. This study was funded in part by the EC-FP6-project DiMI, LSHB-CT-2005-512146.

PII: S0969-8051(07)00191-6

doi: 10.1016/j.nucmedbio.2007.07.011

Nuclear Medicine and Biology
Volume 34, Issue 8 , Pages 967-971 , November 2007

Article Tools

* Image Usage & Resolution